Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of ADACEL in Persons ≥65 Years
NCT00457249Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acellular pertussis vaccine in pertussis, Tetanus, diphtheria, sponsored by Sanofi. Started Mar 2007; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisTetanusdiphtheria
Beyond the preview
Go deeper on NCT00457249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457249.